Executive record

Jennifer Fulk

Most recent record: Kura Oncology, Inc. CFO transition: Jennifer Fulk to succeed Troy E. Wilson, Ph.D., J.D. (named as the incoming officer), effective September 8, 2026. See Kura Oncology, Inc..

1 verified record

2026-09-08 · Transition

Kura Oncology, Inc. CFO transition: Jennifer Fulk to succeed Troy E. Wilson, Ph.D., J.D.

This page lists only verified filing records that name Jennifer Fulk; it is not a career history. Corrections: the corrections page.